New Delhi, March 27 (IANS) Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’, a report said on Friday.The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.The dispute comes as India opens up to generic versions of semaglutide following patent expiry, trigg…
Latest Novo Nordisk News & Updates
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi’s clarion call, obesity became the focus of healthcare in India in 2025.The anti-obesity drive, especially the generic drugs, will continue to remain a key focus in 2026.Traditionally, Body Mass Index (BMI) was used to define obesity, but after 15 long years, India revamped its obesity guidelines in 2025 by lowering the thresh…